SuPAR and Chronic Kidney Disease: Identifying Biomarkers for Disease Progression

Authors

Michael Smith
Darcy Weidemann, Children's Mercy HospitalFollow

Files

Document Type

Podcast

Hosts

Michael Smith

Featured Speaker

Darcy K. Weidemann, MD

Length of Episode

6:37

Description

SuPAR (soluble urokinase-type plasminogen activator receptor) has been shown to be a promising biomarker in its ability to predict the development of chronic kidney disease in adults years earlier than traditional risk factors.

Darcy Weidemann, MD, pediatric nephrologist at Children’s Mercy is leading the largest North American study ever conducted to look at whether suPAR may be helpful to predict kidney function decline in children.

Listen in to Darcy Weidemann, MD as she explains the potential role that monitoring suPAR levels may play in improving the care of children with chronic kidney disease.

Click here to stream the podcast episode.

Publication Date

10-16-2016

Recommended Citation

Smith, Michael and Weidemann, Darcy, "SuPAR and Chronic Kidney Disease: Identifying Biomarkers for Disease Progression" (2016). Transformational Pediatrics Podcast. 71.
https://scholarlyexchange.childrensmercy.org/transformational-peds_podcast/71